Team

 

SV Life Sciences has a team of 34 professionals, of which 27 are deal professionals focusing on our portfolio; identifying investment opportunities, structuring and executing transactions, actively working with portfolio companies on development and growth initiatives and achieving investment realizations. The remaining seven team members are finance professionals who provide essential support to the deal teams and our investors. A key strength of the SV Life Sciences team is the breadth of hands-on operational experience in venture capital investment as well as within the Life Sciences industry across operational, scientific and clinical experience.  

 

 

Managing Partners

Kate Bingham
Kate Bingham
Biotechnology
James Garvey
James Garvey
All Sectors
Tom Flynn
Tom Flynn
Healthcare
Eugene Hill
Eugene Hill
Healthcare
Paul LaViolette
Paul LaViolette
Medical Devices
Michael Ross
Michael Ross
Biotechnology


⇧ Back to top